| abstract |
The present invention provides for compounds of Formula (I) and various embodiments thereof, and compositions comprising compounds of Formula (I) and various embodiments thereof. n n n n n n n n n n In compounds of Formula I, the groups R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 have the meaning as described herein. The present invention also provides for methods of using compounds of Formula I and compositions comprising compounds of Formula (I) as DLK inhibitors and for treating neurodegeneration diseases and disorders. |